Citation Impact

Citing Papers

Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
The Stability Landscape of de novo TIM Barrels Explored by a Modular Design Approach
2021 StandoutNobel
Evaluation of Genetically Engineered Derivatives of a Chinese Strain of Foot-and-Mouth Disease Virus Reveals a Novel Cell-Binding Site Which Functions in Cell Culture and in Animals
2003
Structure of Foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation
2005
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin α v β 3 as Its Receptor
1998
Cell Recognition by Foot-and-Mouth Disease Virus That Lacks the RGD Integrin-Binding Motif: Flexibility in Aphthovirus Receptor Usage
2000
Extracellular vesicles are the Trojan horses of viral infection
2016
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Autophagy during viral infection — a double-edged sword
2018
Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure
1998
Antineutrophil cytoplasmic antibodies
2006
Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential
2015
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Prospects, including time-frames, for improved foot and mouth disease vaccines
2002
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Molecular basis of pathogenesis of FMDV
2003
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
2003 StandoutNature
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Macrophage phagocytosis of foot‐and‐mouth disease virus may create infectious carriers
2002
Antibody recognition of picornaviruses and escape from neutralization: a structural view
1995
Extensive antigenic and genetic variation among foot-and-mouth disease type A viruses isolated from the 1994 and 1995 foci in São Paulo, Brazil
2002
Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine
1999
Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV)
2003
Accumulation of silver nanoparticles by cultured primary brain astrocytes
2011
A Helical RGD Motif Promoting Cell Adhesion: Crystal Structures of the Helicobacter pylori Type IV Secretion System Pilus Protein CagL
2013
Refinement of Protein Structures into Low-Resolution Density Maps Using Rosetta
2009 StandoutNobel
Crystal Structure of the OPG2 Fab
1995
Microbial recognition of target-cell glycoconjugates
1995
The Pathogenesis and Diagnosis of Foot-and-Mouth Disease
2003
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
2010
Evidence for Positive Selection in the Capsid Protein-Coding Region of the Foot-and-Mouth Disease Virus (FMDV) Subjected to Experimental Passage Regimens
2001
Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host
1995
UCSF Chimera—A visualization system for exploratory research and analysis
2004 Standout
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
1999
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies
2000
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Wrapping Things up about Virus RNA Replication
2005
Evolution of foot-and-mouth disease virus
2003
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Aspects of the persistence of foot-and-mouth disease virus in animals—the carrier problem
2002
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
2020 Standout
Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants
1997
Entry of viruses through the epithelial barrier: pathogenic trickery
2003
Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity
1996
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides
1995
The crystal structure of bluetongue virus VP7
1995 Nature
Foot-and-Mouth Disease Virus Lacking the VP1 G-H Loop: The Mutant Spectrum Uncovers Interactions among Antigenic Sites for Fitness Gain
2001
The structure of coxsackievirus B3 at 3.5 å resolution
1995
Periodontal diseases
2005 Standout
Surface Display of Proteins on Bacteriophage λ Heads
1996 StandoutNobel
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Amoebiasis
2003 Standout
The structure and antigenicity of a type C foot-and-mouth disease virus
1994
Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer
2003
Cryo-EM structure of a type IV secretion system
2022 StandoutNatureNobel
Amebiasis
2008
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Alternative activation of macrophages
2003 Standout
Integrin-ligarid interactions: a year in review
1994
Replication of hepatitis C virus
2007 StandoutNobel
Constitutive Expression of Alpha Interferon by Skin Dendritic Cells Confers Resistance to Infection by Foot-and-Mouth Disease Virus
2005
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites
1994
Gut Microbiota in Health and Disease
2010 Standout
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle
1997
Effects of Foot-and-Mouth Disease Virus Nonstructural Proteins on the Structure and Function of the Early Secretory Pathway: 2BC but Not 3A Blocks Endoplasmic Reticulum-to-Golgi Transport
2005
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
1996 Standout
Foot-and-Mouth Disease
2004 Standout
Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV
1994
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide
2019
A Single Amino Acid Substitution in Nonstructural Protein 3A Can Mediate Adaptation of Foot-and-Mouth Disease Virus to the Guinea Pig
2001
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
2005 StandoutScience
Nonviral Vectors for Gene Delivery
2008 Standout
Lectins:  Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells
1995
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus
1997
High-Efficiency Utilization of the Bovine Integrin α v β 3 as a Receptor for Foot-and-Mouth Disease Virus Is Dependent on the Bovine β 3 Subunit
2000
Lethal Mutagenesis of Foot-and-Mouth Disease Virus Involves Shifts in Sequence Space
2011
The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis
2012
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD
1995
Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy
2015
Schistosome Infection Stimulates Host CD4+T Helper Cell and B-Cell Responses against a Novel Egg Antigen, Thioredoxin Peroxidase
2001
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Analysis of Foot-and-Mouth Disease Virus Internalization Events in Cultured Cells
2005
Genetic Determinants of Altered Virulence of Taiwanese Foot-and-Mouth Disease Virus
2000
Evolution subverting essentiality: Dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus
1997
EPIDEMIOLOGIC AND CLINICAL CHARACTERISTICS OF ACUTE DIARRHEA WITH EMPHASIS ON ENTAMOEBA HISTOLYTICA INFECTIONS IN PRESCHOOL CHILDREN IN AN URBAN SLUM OF DHAKA, BANGLADESH
2003
Evidence of the Coevolution of Antigenicity and Host Cell Tropism of Foot-and-Mouth Disease Virus In Vivo
2002
Neural Science
2000 StandoutNobel
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Principles of Protein Stability and Their Application in Computational Design
2018
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Identifying airborne transmission as the dominant route for the spread of COVID-19
2020 StandoutNobel
Multiple Virulence Determinants of Foot-and-Mouth Disease Virus in Cell Culture
1998
Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide.
1994
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
1997 StandoutScience
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
A millennium update on pediatric diarrheal illness in the developing world
2005
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Foot-and-Mouth Disease Virus Receptors: Comparison of Bovine α V Integrin Utilization by Type A and O Viruses
2003
Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging
2015
Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around
1994
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children
2004
VP1 of Foot-and-Mouth Disease Virus Induces Apoptosis via the Akt Signaling Pathway
2004
RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL
1997
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
The Ability of Integrin αvβ3To Function as a Receptor for Foot-and-Mouth Disease Virus Is Not Dependent on the Presence of Complete Subunit Cytoplasmic Domains
2001
A Dynamic View of Hepatitis C Virus Replication Complexes
2008 StandoutNobel
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells
1997
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
A Revolution in Biomedical Assessment: The Development of Salivary Diagnostics
2001
Comparative Genomics of Foot-and-Mouth Disease Virus
2005
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Acid-Resistant Bovine Pestivirus Requires Activation for pH-Triggered Fusion during Entry
2005
Viral Quasispecies Evolution
2012
Impairment of Thymus-Dependent Responses by Murine Dendritic Cells Infected with Foot-and-Mouth Disease Virus
2005
Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa
2001
Experimental Infection of Mongolian Gerbils with Wild-Type and Mutant Helicobacter pylori Strains
1998
Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids
1995
Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229E
2003
Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus
2004
RGD sequence of foot-and-mouth disease virus isessential for infecting cells via the natural receptor but can be bypassed by anantibody-dependent enhancement pathway.
1994
Analysis of a Foot-and-Mouth Disease Virus Type A 24 Isolate Containing an SGD Receptor Recognition Site In Vitro and Its Pathogenesis in Cattle
2005

Works of Terry Jackson being referenced

A Recombinant Cysteine-Rich Section Of The Entamoeba Histolytica Galactoseinhibitable Lectin Is Efficacious As A Subunit Vaccine In The Gerbil Model Of Amebic Liver Abscess
1995
Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design
2015
Capsid Protein VP4 of Human Rhinovirus Induces Membrane Permeability by the Formation of a Size-Selective Multimeric Pore
2014
Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67
1995
A Clathrin Independent Macropinocytosis-Like Entry Mechanism Used by Bluetongue Virus-1 during Infection of BHK Cells
2010
Structure and receptor binding
2003
Diagnosis of Pathogenic Entamoeba histolytica Infection using a Stool ELISA Based on Monoclonal Antibodies to the Galactose-Specific Adhesin
1993
Asymptomatic Intestinal Colonization by Pathogenic Entamoeba histolytica in Amebic Liver Abscess: Prevalence, Response to Therapy, and Pathogenic Potential
1992
Crystallization and preliminary X-ray analysis of three serotypes of foot-and-mouth disease virus
1992
Structure of a major immunogenic site on foot-and-mouth disease virus
1993 Nature
Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody
1994
The ultrastructure of the developing replication site in foot-and-mouth disease virus-infected BHK-38 cells
2004
Role of the Cytoplasmic Domain of the β-Subunit of Integrin αvβ6 in Infection by Foot-and-Mouth Disease Virus
2001
A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica.
1987
Foot-and-Mouth Disease Virus Induces Autophagosomes during Cell Entry via a Class III Phosphatidylinositol 3-Kinase-Independent Pathway
2012
Real-Time PCR for Detection and Differentiation ofEntamoeba histolyticaandEntamoeba disparin Fecal Samples
2002
A Dominant-Negative Mutant of rab5 Inhibits Infection of Cells by Foot-and-Mouth Disease Virus: Implications for Virus Entry
2009
The Epithelial Integrin αvβ6 Is a Receptor for Foot-and-Mouth Disease Virus
2000
FREQUENCY DISTRIBUTION OF ENTAMOEBA HISTOLYTICA ZYMODEMES IN A RURAL SOUTH AFRICAN POPULATION
1985
Guinea Pig-Adapted Foot-and-Mouth Disease Virus with Altered Receptor Recognition Can Productively Infect a Natural Host
2007
Integrin αvβ1 Is a Receptor for Foot-and-Mouth Disease Virus
2002
Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen
1995
Integrin αvβ8 Functions as a Receptor for Foot-and-Mouth Disease Virus: Role of the β-Chain Cytodomain in Integrin-Mediated Infection
2004
Diagnosis of Invasive Amebiasis by Enzyme-Linked Immunosorbent Assay of Saliva To Detect Amebic Lectin Antigen and Anti-Lectin Immunoglobulin G Antibodies
2000
A comparative assessment of commonly employed staining procedures for the diagnosis of cryptosporidiosis.
1991
The Epithelial Integrin αvβ6 Is a Receptor for Foot-and-Mouth Disease Virus
2000
Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin α5β1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding
2000
Integrin α v β 6 Is an RGD-Dependent Receptor for Coxsackievirus A9
2004
Early Events in Integrin αvβ6-Mediated Cell Entry of Foot-and-Mouth Disease Virus
2005
The αvβ6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle
2005
Rankless by CCL
2026